Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Euro Surveill ; 17(24)2012 Jun 14.
Artículo en Inglés | MEDLINE | ID: mdl-22720768

RESUMEN

French military personnel are subject to a compulsory vaccination schedule. The aim of this study was to describe vaccine adverse events (VAE) reported from 2002 to 2010 in armed forces. VAE are routinely surveyed by the military Centre for epidemiology and public health. For each case, military practitioners fill a notification form, providing patient characteristics, clinical information and vaccines administered. For this study, VAE following influenza A(H1N1)pdm09 vaccination were excluded. Among the 473 cases retained, 442 (93%) corresponded to non-severe VAE,including local, regional and systemic events, while 31 corresponded to severe VAE, with two leading to significant disability. The global VAE reporting rate (RR) was 14.0 per 100,000 injections. While stationary from 2002 to 2008, the RR increased from 2009. The most important observations were a marked increase of VAE attributed to Bacillus Calmette-Guérin (BCG) vaccine from 2005 to 2008, a high RR observed with the inactivated diphtheria-tetanus (toxoids)-poliovirus vaccine combined with acellular pertussis vaccine (dTap-IPV) from 2008 and an increase in RR for seasonal influenza vaccine VAE in 2009. Our RR for severe VAE (1.1 VAEper 100,000) appears comparable with rates observed among United States civilians and military personnel. The increase observed from 2009 could be partly explained by the influenza A(H1N1)pdm09 pandemic which increased practitioner awareness towards VAE. In conclusion, the tolerance of the vaccines used in French armed forces appears acceptable.


Asunto(s)
Sistemas de Registro de Reacción Adversa a Medicamentos/estadística & datos numéricos , Vacunación Masiva/estadística & datos numéricos , Personal Militar/estadística & datos numéricos , Vigilancia de la Población , Vacunas/efectos adversos , Adulto , Sistemas de Registro de Reacción Adversa a Medicamentos/tendencias , Algoritmos , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/epidemiología , Francia/epidemiología , Humanos , Programas de Inmunización , Esquemas de Inmunización , Masculino , Vacunación Masiva/tendencias , Análisis Multivariante , Estaciones del Año , Índice de Severidad de la Enfermedad , Distribución por Sexo , Factores de Tiempo , Vacunas/administración & dosificación
2.
Euro Surveill ; 16(23)2011 Jun 09.
Artículo en Inglés | MEDLINE | ID: mdl-21679676

RESUMEN

On 12 June 2009, Morocco was the first country in North Africa to report a laboratory-confirmed case of influenza A(H1N1)2009 virus infection. This study describes the epidemiological and clinical characteristics of 240 laboratory-confirmed cases among 594 outpatients with influenza-like illness at the Mohammed V Military Teaching Hospital, Rabat, from 12 June to 24 December 2009. Real-time reverse transcription-PCR was used to confirm the infection. The epidemic peaked in weeks 47 to 49 (16 November to 6 December 2009). The mean age of cases was 23 years (standard deviation: 14 years). Cough was the most common symptom in 200 cases (83%), followed by fever (≥38 °C) in 195 (81%). Diarrhoea or vomiting was reported in 12 (5%) patients. None of the cases developed any complications and no deaths occurred during the study period.


Asunto(s)
Hospitales Militares/estadística & datos numéricos , Hospitales de Enseñanza/estadística & datos numéricos , Subtipo H1N1 del Virus de la Influenza A , Gripe Humana/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Marruecos/epidemiología , Prevalencia , Adulto Joven
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda